Research Articles on Tuberculosis from 1940 onwards

Comparing the Efficacy of Ceftazidime and Meropenem in Treatment of Febrile Neutropenia in Pediatric Patients with Cancer
Iran J Ped Hematol Oncol. 2013; 3(3): 103–107.
Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital
Infect Drug Resist. 2015; 8: 31–38.
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
PLoS One. 2019 Feb 6;14(2):e0211096.
Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection.
Biomed Res Int. 2014;2014:158520.
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Curr Med Res Opin. 2012 Dec;28(12):1921-31.
High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial.
PLoS One. 2018 May 8;13(5):e0196734.
Comparison of twice a day and three times a day meropenem administration in elderly patients in a Japanese community hospital
Nagoya J Med Sci. 2018 Aug; 80(3): 391–400.
Imipenem-cilastatin-induced psychosis: a case report.
J Med Case Rep. 2016 Apr 27;10(1):107.
Pharmacokinetics of Meropenem for Use in Bacterial Keratitis.
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5731-8.
Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge